Hikma Pharmaceuticals PLC.

Company Snapshot

Founded: 1978
Entity Type: Public
Employees: 9,500
Region: North America
Revenue: $3,127.0 Millions
Revenue Year: 2024
Headquarter: London, U.K.
Key Geographics: North America, Middle East, North Africa, Europe, U.K., Rest of the World
Corporate Address: 1 New Burlington Place London, W1S 2HR U.K. Tel. +44-0-20-7399-2760 www.hikma.com

Company Overview

Hikma Pharmaceuticals provides a range of branded, generic and specialty pharmaceutical products to the U.S., MENA and Europe. It supplies hospitals in these regions with generic injectables supported by its manufacturing facilities, which are located in these regions. In the U.S., Hikma has broadened its product offerings to include compound sterile injectables. It supplies oral and other non-injectable generic and specialty branded products to the U.S. retail market. It operates a manufacturing facility in Columbus, Ohio. The company also provides branded generics and in-licensed patented products from its local manufacturing facilities to retail and hospital customers across the MENA region.

Financial Highlights (FY 2024)

Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***

This information is available for BCC Research members only.

Hikma Pharmaceuticals PLC. In Reports

Cardiovascular Drugs: Global Markets to 2030

BCC Research detailed report on cardiovascular drugs market global revenue ($ million) for the base year 2024 and estimated data for the forecast period 2025 through 2030.

Psychedelic Drugs: Global Market Outlook

BCC Research Market Report says psychedelic drugs market is projected to grow from $3.7 bln in 2021 to $5.7 bln in 2027, at a compound annual growth rate of 7.5%.

Sleep Disorders Treatment: Global Market Outlook

BCC Research Market Analysis Report says sleep disorders treatment market is projected to grow from $17.2 bln in 2021 to $28.0 bln in 2027, at a CAGR of 8.6%.

Company's Business Segments

  • Injectables : The company supplies hospitals across its markets with generic and specialty injectable products, supported by our US, Europe, and MENA manufacturing facilities.
  • Generics : The company offers branded generics and in-licensed patented products from its local manufacturing facilities to retail and hospital customers across the MENA region.
  • Branded : The company supplies oral, respiratory, and other generic and specialty products to the North American retail market, leveraging its advanced manufacturing facility in Columbus, Ohio.

Applications/End User Industries

  • Pharmaceutical Manufacturing
AI Sentiment